Ursprung des Netzwerks ersten Grades von Motoki Nakai
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Curreio, Inc.
 Curreio, Inc. Pharmaceuticals: MajorHealth Technology Curreio, Inc. is a drug discovery startup company founded in August 2019 and based in Tokyo, Japan. The Japanese company specializes in cryo-EM structural analysis technology and has unique technologies and know-how in protein production and purification, grid preparation, and 3D structural analysis. Curreio is currently developing internal/collaborative drug discovery projects and drug discovery support services for pharmaceutical companies using their cryo-EM technologies. The company's goal is to expand the possibilities of drug discovery for challenging proteins and protein-supramolecular complexes through structural analysis. The CEO is Motoki Nakai.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Motoki Nakai
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Biotechnology | Founder | |
| University of Tokyo | College/University | Corporate Officer/Principal |
Statistik
International
| Japan | 3 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Operativ
| Director/Board Member | 2 |
| Founder | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Osamu Nureki | 3 |
- Börse
- Insiders
- Motoki Nakai
- Unternehmensverbindungen
